Institutional Corruption and Pharmaceutical Policy

For more complete information on this JLME issue, see the Press Release about this publication.

Lab fellows from the Edmond J. Safra Center put together 16 articles that investigate the corruption of pharmaceutical policy, each taking a different look at the sources of corruption, how it occurs and what is corrupted. The articles address five topics: (1) systemic problems, (2) medical research, (3) medical knowledge and practice, (4) marketing, and (5) patient advocacy organizations. They are now available online and will appear in the fall issue of The Journal of Law, Medicine & Ethics.

For a summary of each article and the key themes see, Marc Rodwin, Institutional Corruption and Pharmaceutical Policy.

 


Institutional Corruption and Pharmaceutical Policy
(forthcoming)
Journal of Law, Medicine and Ethics
Vol. 41, No. 3 (2013)

1. SYSTEMIC PROBLEMS

2. MEDICAL RESEARCH

3. MEDICAL KNOWLEDGE AND PRACTICE

4. MARKETING

5. PATIENT ADVOCATES